ArticleEFSA journal. European Food Safety Authority2019
Updated statement on the available outcomes of the human health assessment in the context of the pesticides peer review of the active substance chlorpyrifos-methyl.
Article in EFSA journal. European Food Safety Authority, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Application, ecotoxicology and regulation of insecticides with special reference to neonicotinoids.Fly · 2026Review
- Peer review of the pesticide risk assessment of the active substance triclopyr (variant triclopyr-butotyl).EFSA journal. European Food Safety Authority · 2024Review
- Assessment of exposure to pesticides: residues in 24 h duplicate diets versus their metabolites in 24 h urine using suspect screening and target analysis.Analytical and bioanalytical chemistry · 2024Observational
- Challenges in the Application of Circular Economy Models to Agricultural By-Products: Pesticides in Spain as a Case Study.Foods (Basel, Switzerland) · 2023Article
- Modification of the existing maximum residue levels for triclopyr in animal commodities.EFSA journal. European Food Safety Authority · 2023Article
- Modification of the existing maximum residue levels for triclopyr in oranges, lemons and mandarins.EFSA journal. European Food Safety Authority · 2022Article
- Article
- Scientific support for preparing an EU position for the 52nd Session of the Codex Committee on Pesticide Residues (CCPR).EFSA journal. European Food Safety Authority · 2021Article
- Updated statement on the available outcomes of the human health assessment in the context of the pesticides peer review of the active substance chlorpyrifos-methyl.EFSA journal. European Food Safety Authority · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In July 2019, the European Commission asked EFSA to provide a statement on the available outcomes of the human health assessment in the context of the pesticides peer review for the renewal of approval of the active substance chlorpyrifos-methyl conducted in accordance with Commission Implementing Regulation (EC) No 844/2012. Accordingly, EFSA delivered a statement to the Commission providing a summary of the main findings of the assessment related to human health following the pesticides peer review expert discussions in mammalian toxicology held between 1 and 5 April 2019, as well as EFSA's additional considerations, including whether the active substance can be expected to meet the approval criteria applicable to human health as laid down in Article 4 of Regulation (EC) No 1107/2009. A follow-up mandate was received to update the statement issued on 31 July 2019 with the outcome of the expert meeting in mammalian toxicology held on 5 September 2019 during which chlorpyrifos-methyl was rediscussed. The concerns identified in the previous statement are maintained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.